BMO Capital analyst Ryan Thompson maintains GoGold Resources (TSX:GGD) with a Outperform and raises the price target from C$3.4 to C$3.5.
Raymond James Upgrades Myriad Genetics to Outperform, Announces $25 Price Target
Raymond James analyst Andrew Cooper upgrades Myriad Genetics (NASDAQ:MYGN) from Market Perform to Outperform and announces $25 price target.